4th Gene Therapy Patient Engagement Summit

Kongressthemen
Patient engagement is a crucial responsibility of any gene therapy company that is serious about progressing safe, effective, and meaningful therapies to patients.

The 4th Gene Therapy Patient Engagement Summit is returning in 2024, sitting at the unique interface of patient engagement and gene therapy, from embarking on first-in-human trials through to commercial therapeutics.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
URL:
Brochure: https://go.evvnt.com/2174655-3?pid=4832

Speakers: Oscar Segurado, Clinical Development, ASC Therapeutics, Kara Fick, Director, Patient Advocacy and Medical Affairs, Atsena, and more

https://go.evvnt.com/2174655-1?pid=4832

Frau Jasmine Fletcher